Within the area of global animal health, Irish companies have a long history of excelling on the world stage, and perhaps none more so than Bimeda.
Founded in Ireland in 1960 and still headquartered in Dublin, Bimeda has been anticipating the needs of the global animal health sector for over six decades. Bimeda’s veterinary pharmaceuticals and animal health products are found in over 75 countries and the company is a renowned global leader in animal health.
Innovation is in Bimeda’s DNA. As far back as the 1970s, the company won acclaim for developing the first intramammary teat sealant, and today unique products such as their soluble glass trace element boluses ensure that they continue to stand out from the crowd.
Gavin Tierney, Group CEO of Bimeda, explained, “Since starting out in Ireland over 60 years ago, Bimeda has transformed into a leading global player and innovator in the industry. Innovation drives us, and our global innovation center in Ireland collaborates with our five state-of-the-art R&D laboratories in four continents, creating a pipeline of science-led solutions to optimize the health of the world’s animals.”
Bimeda is now a major presence in the US animal health market, with products available through all major animal health providers. The company also boasts four manufacturing facilities in the USA, producing a wide range of veterinary medicines as well as livestock and fish vaccines.
For a case study on Ireland’s ability to nurture innovation and export excellence, look no further than Bimeda.